70 related articles for article (PubMed ID: 31339226)
1. Congenital spindle cell rhabdomyosarcoma.
Whittle SB; Hicks MJ; Roy A; Vasudevan SA; Reddy K; Venkatramani R
Pediatr Blood Cancer; 2019 Nov; 66(11):e27935. PubMed ID: 31339226
[TBL] [Abstract][Full Text] [Related]
2. Recurrent NCOA2 gene rearrangements in congenital/infantile spindle cell rhabdomyosarcoma.
Mosquera JM; Sboner A; Zhang L; Kitabayashi N; Chen CL; Sung YS; Wexler LH; LaQuaglia MP; Edelman M; Sreekantaiah C; Rubin MA; Antonescu CR
Genes Chromosomes Cancer; 2013 Jun; 52(6):538-50. PubMed ID: 23463663
[TBL] [Abstract][Full Text] [Related]
3. [Congenital spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological analysis].
Xu JT; Fu LB; Yao XF; Jia C; Guan XX; Zhang M; He LJ
Zhonghua Bing Li Xue Za Zhi; 2024 Apr; 53(4):344-350. PubMed ID: 38556817
[No Abstract] [Full Text] [Related]
4. Intraosseous Spindle Cell Rhabdomyosarcoma with
Smith BF; Doung YC; Beckett B; Corless CL; Davis LE; Davis JL
Cancer Invest; 2023 Sep; 41(8):704-712. PubMed ID: 37668330
[TBL] [Abstract][Full Text] [Related]
5. VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesis.
Watson S; LaVigne CA; Xu L; Surdez D; Cyrta J; Calderon D; Cannon MV; Kent MR; Silvius KM; Kucinski JP; Harrison EN; Murchison W; Rakheja D; Tirode F; Delattre O; Amatruda JF; Kendall GC
Cell Rep; 2023 Jan; 42(1):112013. PubMed ID: 36656711
[TBL] [Abstract][Full Text] [Related]
6. An infant with ETV6-NTRK3 fusion-positive congenital infantile fibrosarcoma and delayed response to conventional chemotherapy avoiding the need for TRK inhibition.
Vedi A; Holland K; Cross J; Muthusamy B; Behjati S; Hook CE; Murray MJ
Pediatr Blood Cancer; 2020 Oct; 67(10):e28628. PubMed ID: 32748441
[No Abstract] [Full Text] [Related]
7. Left cheek sclerosing rhabdomyosarcoma and development of isolated free flap donor site metastasis.
Zhou D; Bhadri V; Luk P; Ch'ng S; Franks D; Hong A
BMJ Case Rep; 2022 Apr; 15(4):. PubMed ID: 35393277
[TBL] [Abstract][Full Text] [Related]
8. A case of spindle cell rhabdomyosarcoma with a ZFP64::NCOA3 fusion.
Yoshida KI; Kukita Y; Nakamura H; Wakamatsu T; Honma K; Yagi T
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23212. PubMed ID: 37905771
[No Abstract] [Full Text] [Related]
9. Nocardiosis in an infant with spindle cell rhabdomyosarcoma treated with mild immunosuppressive chemotherapy.
Timothy LD; Healy CM; Quintanilla NM; Montgomery N; Okcu MF
Pediatr Blood Cancer; 2024 Apr; 71(4):e30873. PubMed ID: 38259045
[No Abstract] [Full Text] [Related]
10. Conjunctival Spindle Cell/Sclerosing Rhabdomyosarcoma.
Su YW; Wang LC; Fan NW
Ophthalmology; 2023 Oct; ():. PubMed ID: 37877920
[No Abstract] [Full Text] [Related]
11. The current landscape of rhabdomyosarcomas: an update.
Leiner J; Le Loarer F
Virchows Arch; 2020 Jan; 476(1):97-108. PubMed ID: 31696361
[TBL] [Abstract][Full Text] [Related]
12. Challenges in the Diagnosis of Pediatric Spindle Cell/Sclerosing Rhabdomyosarcoma.
Chen S; Rudzinski ER; Arnold MA
Surg Pathol Clin; 2020 Dec; 13(4):729-738. PubMed ID: 33183730
[TBL] [Abstract][Full Text] [Related]
13. Epithelioid and spindle cell rhabdomyosarcoma with FUS-TFCP2 or EWSR1-TFCP2 fusion: report of two cases.
Chrisinger JSA; Wehrli B; Dickson BC; Fasih S; Hirbe AC; Shultz DB; Zadeh G; Gupta AA; Demicco EG
Virchows Arch; 2020 Nov; 477(5):725-732. PubMed ID: 32556562
[TBL] [Abstract][Full Text] [Related]
14. Establishment and Characterization of a Sclerosing Spindle Cell Rhabdomyosarcoma Cell Line with a Complex Genomic Profile.
Schleicher S; Grote S; Malenke E; Chan KC; Schaller M; Fehrenbacher B; Riester R; Kluba T; Frauenfeld L; Boesmueller H; Göhring G; Schlegelberger B; Handgretinger R; Kopp HG; Traub F; Boehme KA
Cells; 2020 Dec; 9(12):. PubMed ID: 33322555
[TBL] [Abstract][Full Text] [Related]
15. Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease: A Study of 4 Aggressive Cases With Clinical, Pathologic, Molecular, and Radiologic Findings.
Cyrta J; Gauthier A; Karanian M; Vieira AF; Cardoen L; Jehanno N; Bouvet M; Bouvier C; Komuta M; Le Loarer F; Orbach D; Rome A; Minard-Colin V; Brichard B; Pluchart C; Thebaud E; Renard M; Pannier S; Brisse H; Petit P; Benoist C; Schleiermacher G; Geoerger B; Vincent-Salomon A; Fréneaux P; Pierron G
Am J Surg Pathol; 2021 Jun; 45(6):854-867. PubMed ID: 33949344
[TBL] [Abstract][Full Text] [Related]
16. MYOD1 as a prognostic indicator in rhabdomyosarcoma.
Ahmed AA; Habeebu S; Farooqi MS; Gamis AS; Gonzalez E; Flatt T; Sherman A; Surrey L; Arnold MA; Conces M; Koo S; Dioufa N; Barr FG; Tsokos MG
Pediatr Blood Cancer; 2021 Sep; 68(9):e29085. PubMed ID: 33913590
[TBL] [Abstract][Full Text] [Related]
17. [Spindle cell/sclerosing rhabdomyosarcoma: a clinicopathological study of 20 cases].
Yang L; Zhang HJ; Yang SJ
Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):336-342. PubMed ID: 32268670
[No Abstract] [Full Text] [Related]
18. Neuroblastoma in a Neonate: A Case Report.
Jnah AJ; Evans SK; Sewell K; Trembath A
Neonatal Netw; 2019 Nov; 38(6):341-347. PubMed ID: 31712398
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics, Treatment Considerations, and Outcomes of Infants with Rhabdomyosarcoma.
Yan AP; Venkatramani R; Bradley JA; Lautz TB; Urla CI; Merks JHM; Oberoi S
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190224
[TBL] [Abstract][Full Text] [Related]
20. Comparison of
Shen Z; Wang R
Diagnostics (Basel); 2023 Sep; 13(18):. PubMed ID: 37761371
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
